(Q34326923)

1 August 2017

title

The significance of α-synuclein, amyloid-β and tau pathologies in Parkinson's disease progression and related dementia (English)

1 reference

1 August 2017

1 reference

1 reference

7

Andrew J Lees

1 reference

1 August 2017

5

Tammaryn Lashley

1 reference

1 August 2017

6

Janice L Holton

1 reference

1 August 2017

Yaroslau Compta

1

1 reference

1 August 2017

Laura Parkkinen

2

1 reference

1 August 2017

Peter Kempster

3

1 reference

1 August 2017

Mariana Selikhova

4

1 reference

1 August 2017

Tamas Revesz

8

1 reference

1 August 2017

language of work or name

1 reference

11 September 2013

1 reference

Neurodegenerative Diseases

1 August 2017

published in

1 reference

1 August 2017

volume

13

1 reference

1 August 2017

issue

2-3

1 reference

1 August 2017

page(s)

154-156

1 reference

Distinct α-synuclein strains differentially promote tau inclusions in neurons

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Neuropathologic substrates of Parkinson disease dementia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Parkinson disease with dementia: comparing patients with and without Alzheimer pathology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

A clinico-pathological study of subtypes in Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Striatal beta-amyloid deposition in Parkinson disease with dementia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

CSF markers for incipient Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Staging of brain pathology related to sporadic Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

The progression of pathology in longitudinally followed patients with Parkinson's disease.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4194631

Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24028925

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000354670

1 reference

1 August 2017

1 reference

1 August 2017

1 reference